ANAnastasia Nikolaeva

Anastasia Nikolaeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasia Nikolaeva has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of Antimicrobial Therapy on the Development of Microbiota in Infants

    by Tatiana Priputnevich, Pavel Denisov, Ksenia Zhigalova, Vera Muravieva, Natalia Shabanova, Alexey Gordeev, Viktor Zubkov, Bayr Bembeeva, Elena Isaeva, Anastasia Nikolaeva, et al.

    Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.

  • Influence of the vaginal and intestinal microbiota of a pregnant woman on course of postpartum period

    by A.A. Kozlova, T.V. Priputnevich, A.V. Nikolaeva, I.I. Baranov, I.V. Meshalkina, Z.F. Akhmedova, P.A. Denisov, V.V. Muravieva, E.D. Kirillova, A.P. Cherdantsev

  • Development of the gut microbiota of term and late preterm newborn infants

    by T.V. Priputnevich, E.L. Isaeva, V.V. Muravieva, M.K. Mesyan, V.V. Zubkov, A.V. Nikolaeva, B.O. Bembeeva, L.A. Timofeeva, A.A. Kozlova, S.M. Yudin

    Становление микробиоты кишечника доношенных и поздних недоношенных детей, рожденных самопроизвольно и путем операции кесарева сечения